NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Medicenna Therapeutics Corp. (TSX: MDNA; OTCQX: MDNAF), a clinical-stage immunotherapy company, has qualified to trade on the OTCQX(R) Best Market. Medicenna Therapeutics Corp. upgraded to OTCQX from the […]

GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announces a mandatory separation of its units, which trade under the ticker symbol “PHGE.U”, each of which consists of one share of Common

— Topline Results Expected Q2 2025 — WATERTOWN, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting anti-inflammatory therapies for the localized treatment of chronic rhinosinusitis (CRS), today announced that the pivotal Phase 3 ENLIGHTEN 2 clinical trial of LYR-210 in adult

DALLAS, Oct. 15, 2024 (GLOBE NEWSWIRE) — CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced that it will report its third quarter 2024 financial results on October 29, 2024, premarket. The Company will also host its earnings call starting at

MIAMI, Oct. 15, 2024 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard(TM) Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the establishment of its global headquarters in Miami, Florida. The new facility will ideally position the Company to support the anticipated U.S. launch and commercialization of the CGuard

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (TSX: MHC.U) (TSX:MHC.UN) (“Flagship” or the “REIT”) today announced that senior management will host a conference call on Thursday, November 14, 2024 at 8:30 a.m. ET to discuss the

Versius granted marketing authorization through FDA’s De Novo process which establishes initial indication for adults undergoing cholecystectomy Globally, Versius is the second most utilized surgical robotic system, with over 26,000 surgical procedures completed across Europe, Latin America, Asia, Middle East and Africa With its unique compact design and portability, Versius can increase surgical options for

Avacta Group plc (“Avacta” or “the Group” or “the Company”) Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer London, Oct. 15, 2024 – Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announced the appointment of seasoned scientific leader Michelle Morrow, PhD

Special offer for past and present military members available on Monday, Nov. 11 White Castle®, the well-known fast-food and consumer packaged-goods company, is celebrating Veterans Day by offering a free individual combo meal or a breakfast combo meal to all veterans and active-duty service members who dine at a participating White Castle restaurant. The special

Tempur Sealy International, Inc.(NYSE: TPX) will release its financial results for the third quarter endedSeptember 30, 2024, before theNYSEopening of regular trading onThursday, November 7, 2024. The Company will hold a conference call at8:00 a.m. Eastern Time. The call will be webcast and can be accessed on the Company’s investor relations website at investor.tempursealy.com. After